Performance of Multidetector Computed Tomography and Negative Versus Positive Enteric Contrast for Evaluation of Gastrointestinal Neuroendocrine Neoplasms
- 4 March 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 46 (3) , 333-343
Abstract
Background: Routine computed tomography (CT) scans are thought to have poor performance for detection of gastrointestinal (GI) neuroendocrine neoplasms (NENs), which leads to delayed workup. Detection of even 1 bowel tumor can guide diagnostic workup and management. The purposes of this study were to assess the accuracy of multidetector computed tomography (MDCT) and to compare negative versus positive enteric contrast in detecting at least 1 GI tumor per patient with suspected or confirmed diagnosis of a NEN. Methods: This retrospective study included 107 patients with intravenous and oral contrast (65 positive, 40 negative, and 2 no oral contrast) abdominopelvic MDCT. Two abdominal radiologists independently analyzed the CTs for detection and localization of bowel NENs. Surgical pathology was considered the reference standard. Analyses included κ and summary statistics, McNemar test, Pearson χ2 test, and Fisher exact test. Results: Among the 107 CT scans, there were 30 pathology negative studies and 77 studies with positive pathology for GI NEN. Interreader agreement for CT evaluation was substantial (κ = 0.61). At least 1 GI NEN per patient was detected with 51% to 53% sensitivity, 87% to 93% specificity, 91% to 95% positive predictive value (PPV), 42% negative predictive value, and 63% accuracy for each reader, and 57% accuracy when only the concordant (ie, matching) results of the 2 readers were considered. Computed tomography scans with negative enteric contrast had significantly higher sensitivity for concordant results than CTs with positive enteric contrast (58% vs 30%, P = 0.01). Specificity (100% vs 95%, P = 0.5), PPV (100% vs 93%, P = 0.49), negative predictive value (39% vs 39%, P = 0.99), and accuracy (67% vs 51%, P = 0.10) were not significantly different for negative versus positive enteric contrast for the concordant results. There was no significant difference in GI NEN localization between the readers. Conclusions: Routine MDCT with either positive or negative enteric contrast can detect at least 1 GI tumor per patient with more than 90% PPV and more than 50% accuracy in patients suspected of GI NEN. Using negative enteric contrast improves sensitivity for GI NEN versus positive enteric contrast. In addition, there is high accuracy in localizing the bowel tumor with positive or negative enteric contrast, which may guide surgery. Radiologists should have heightened awareness that evaluating such scans closely may lead to detection of primary bowel NENs at a higher rate than previously reported.Keywords
This publication has 43 references indexed in Scilit:
- Surgery for metastatic neuroendocrine tumors with occult primariesJournal of Surgical Research, 2013
- CT-Enterography May Identify Small Bowel Tumors Not Detected by Capsule Endoscopy: Eight Years Experience at Mayo Clinic RochesterDigestive Diseases and Sciences, 2011
- Value of CT Enteroclysis in Suspected Small-Bowel Carcinoid TumorsAmerican Journal of Roentgenology, 2010
- Midgut neuroendocrine tumours with liver metastases: results of the UKINETS studyEndocrine-Related Cancer, 2009
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological ExaminationsNeuroendocrinology, 2008
- Carcinoid Tumors of the Small Bowel: A Multitechnique Imaging ApproachAmerican Journal of Roentgenology, 2004
- Multidetector-Row Computed Tomography and 3-Dimensional Computed Tomography Imaging of Small Bowel NeoplasmsJournal of Computer Assisted Tomography, 2004
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Small-Bowel TumorsJournal of the American College of Surgeons, 1998
- Midgut Carcinoid TumorsJournal of Computer Assisted Tomography, 1995